Cross-Sectional Iloperidone IVGTT
Condition(s):Schizophrenia; Serious Mental Illness; Metabolic Syndrome; Insulin Resistance; Glucose MetabolismLast Updated:March 12, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Schizophrenia; Serious Mental Illness; Metabolic Syndrome; Insulin Resistance; Glucose MetabolismLast Updated:March 12, 2019Completed
Condition(s):Psychotic DisordersLast Updated:April 25, 2017Completed
Condition(s):Bipolar DisorderLast Updated:February 4, 2022Completed
Condition(s):SchizophreniaLast Updated:January 23, 2019Completed
Condition(s):Stable SchizophreniaLast Updated:March 19, 2021Completed
Condition(s):StrokeLast Updated:August 9, 2019Completed
Condition(s):SchizophreniaLast Updated:March 27, 2020Completed
Condition(s):SchizophreniaLast Updated:March 29, 2021Completed
Condition(s):Adverse Drug Events; Adverse Drug Reactions; Drug Interaction Potentiation; Drug Metabolism, Poor, CYP2D6-RELATED; Drug Metabolism, Poor, CYP2C19-RELATED; Cytochrome P450 Enzyme Deficiency; Cytochrome P450 CYP2D6 Enzyme Deficiency; Cytochrome P450 CYP2C9 Enzyme Deficiency; Cytochrome P450 CYP2C19 Enzyme Deficiency; Cytochrome P450 CYP3A Enzyme Deficiency; Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant; Poor Metabolizer Due to Cytochrome P450 CYP2C19 Variant; Poor Metabolizer Due to Cytochrome P450 CYP2D6 VariantLast Updated:March 1, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.